{{Rsnum
|rsid=1269056
|Gene=ESR2
|Chromosome=14
|position=64277172
|Orientation=minus
|GMAF=0.3214
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ESR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 16.8 | 47.8 | 35.4
| HCB | 7.3 | 47.4 | 45.3
| JPT | 13.3 | 48.7 | 38.1
| YRI | 0.0 | 10.2 | 89.8
| ASW | 3.5 | 17.5 | 78.9
| CHB | 7.3 | 47.4 | 45.3
| CHD | 7.3 | 48.6 | 44.0
| GIH | 19.8 | 51.5 | 28.7
| LWK | 0.0 | 10.0 | 90.0
| MEX | 24.1 | 44.8 | 31.0
| MKK | 0.0 | 16.7 | 83.3
| TSI | 19.6 | 36.3 | 44.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=19321582
|Title=The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor {alpha} and {beta} Genes.
}}

{{PMID Auto
|PMID=16118344
|Title=Polymorphisms in the estrogen receptor beta (ESR2) gene are associated with bone mineral density in Caucasian men and women.
|OA=1
}}

{{PMID Auto
|PMID=18053221
|Title=Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
|OA=1
}}

{{PMID Auto
|PMID=19875614
|Title=A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}